UK-based biotech Synthace has secured £1.3m ($2.09m) in seed backing in a round led by venture firm Sofinnova Partner’s Green Seed Fund and joined by angel investors. The University College London (UCL) spin-out, founded in 2011, is developing a platform of technologies aimed at the rapid engineering and optimisation of biological production systems. Through utilising…
Synthace sees green
Sep 27, 2013 •
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
Resistance is futile: seven superconductor companies that want to change the world
From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.
UK universities urged to lower spinout stakes
A new report recommends stakes of less than 25% but fails to address the issue of access to early-stage capital.
Feb 7, 2024
Mar 14, 2024
Monterey, CA (USA)
Jun 26, 2024